Glufosinate Market Projected size Gain Significant Value by 2026

Global Glufosinate Market was sized US$1.4 Bn in 2017 and is anticipated to reach US$4.3 Bn by 2026 at a CAGR of about 14.72 % during a forecast Period.

Global Glufosinate market is segmented by Crop type, by foam, application, and by region. In terms of crop type, Genetically Modified Crops, Conventional Crops. Liquid Formulation, Dry Formulation is the foam segment of the Glufosinate market. Agricultural, Non-Agricultural are application segment of Glufosinate market. Geographically into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Request for Report Sample: https://www.trendsmarketresearch.com/report/sample/10695


The Foam Glufosinate is a broad-spectrum herbicide produced by Streptomyces soil bacteria which is used to control important weeds named morning glories, yellow nutsedge, and hemp sesbania. The Foam is applied to immature plants at early development stage for better results. Its usage is significantly safe when compared to other herbicides and can be used in combination with other herbicides.

An increasing use of genetically modified crops owing to its cost-effective characteristic and weed controlling properties will boost glufosinate market demand. Herbicide-tolerant crops occupy the largest planting area of biotech crops. Increase in the area for cultivation of herbicide-tolerant crops is expected to upsurge Foam market growth.

The soluble (liquid) concentrate segment occupied more than half of the share in 2015 and is expected to maintain its lead throughout the forecast period. Presence of amine (ammonium salt) or mineral salt in the molecules of formulation enables water solubility which makes it most preferred in the glufosinate industry.

The agricultural applications segment accounted for a larger share in the Glufosinate Market in terms of both, value and volume, in 2015. Glufosinate is used in no-tillage agriculture, which helps farmers in controlling grasses and broad-leaved weeds in a range of agricultural and horticultural crops.

In the year 2017, North America and Asia-Pacific collectively accounted for nearly two-thirds of the global demand for glufosinate and are expected to maintain their lead position throughout the period under consideration. However, Asia-Pacific is projected to be the fastest growing segment, with a CAGR of 21.4%, followed by North America.

Bayer Crop Science, Lier Chemical Company Ltd., Zhejiang Yongnong Chem. Ind. Co., Ltd., Hebei Veyong Biochemical Co., Ltd., UPL Ltd., Jiangsu Huangma Agrochemicals Co., Ltd., Inner Mongolia Jiaruimi Fine Chemical Co., Ltd., Hebei Bestar Bio-Technology Co., Ltd., Jiangsu Seven continent Green Chemical Co., Ltd., Nufarm, Syngenta, the DOW Chemical, Zhejiang Yongnong Chemical,, United Phosphorus, Syngenta AG, Lier Chemical Company Ltd., Nufarm Limit, Bayer AG, Du Pont, Inner Mongolia Jiaruimi Fine Chemical Co. Ltd is key players included in the Glufosinate market.

Request for Report Discount: https://www.trendsmarketresearch.com/report/discount/10695


Scope of Global Glufosinate Market:
Global Glufosinate Market by Crop Type:
Genetically Modified Crops
Conventional Crops
Global Glufosinate Market by Foam:
Liquid Formulation
Dry Formulation
Global Glufosinate Market by Application:
Agricultural
Non Agricultural
Global Glufosinate Market by Region:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Key Player in the Global Glufosinate Report:
Bayer Crop Science
Lier Chemical Company Ltd.
Zhejiang Yongnong Chem. Ind. Co. Ltd.
Hebei Veyong Bio-chemical Co. Ltd.
UPL Ltd.
Jiangsu Huangma Agrochemicals Co. Ltd.
Inner Mongolia Jiaruimi Fine Chemical Co. Ltd.
Hebei Bestar Bio-Technology Co. Ltd.
Jiangsu Seven continent Green Chemical Co.Ltd.
Nufarm
Syngenta
the DOW Chemical
Zhejiang Yongnong Chemical
United Phosphorus
Syngenta AG
Lier Chemical Company Ltd.
Nufarm Limit
Bayer AG
Du Pont
Inner Mongolia Jiaruimi Fine Chemical Co. Ltd

Full View of Report Description: https://www.trendsmarketresearch.com/report/analysis/MMR/global-glufosinate-market